Ontario Institute for Cancer Research (OICR)
To stimulate collaborative research with the Ontario cancer research community in the area of cancer therapeutic discovery, OICR invites applications for early stage drug discovery. Please see details in Request for Applications document and application form: https://oicr.on.ca/funding-opportunities/
Ontario Institute for Cancer Research (OICR) is launching a new funding opportunity for early stage drug discovery. OICE has established the cancer Therapeutics Innovation Pipeline (CTIP) strategic initiative to capitalize on Ontario's expertise in cancer biology and drug discovery. CTIP aims to support the translation of Ontario discoveries into therapeutic assets with the potential for improving the lives of cancer patients.
Investigators at Ontario academic institutions, small biotechs or start-up companies seeking support for early stage drug discovery are eligible to apply.
Funding will be available to support projects in two stages of pre clinical drug discovery: Accelerator and Incubator Projects.
Early Accelerator Projects will be funded up to $100,000 per year for a maximum of one year (expected completion is 6-9 months)
Late Accelerator Projects will be funded up to $250,000 per year for a maximum of two years (expected completion is 15-18 months)
Incubator Projects will be funded up to $2,000,000 over two years
If College-level review is required, your College will communicate its earlier internal deadlines.
Note: this deadline is for registration
Please submit your full proposal with a signed OR5 form to Office of Research at email@example.com